EPA 2018: 26th European Congress of Psychiatry
March 3 - March 6
We are delighted to join EPA for the 4th time.
We will showcase our neurostimulation platform Sooma tDCS, which brings unparalleled ease of use and patient comfort to the treatment of depression and chronic pain. With our remote patient management software and a novel patient contact interface, we provide the world-leading solution for home-based transcranial direct current stimulation. At EPA 2018, we are also looking for research collaboration in the treatment of schizophrenia and addictions.